MiniMed director Linnea Burman files Form 3

MiniMed Group, Inc. director Linnea Burman has filed an initial Form 3 reporting status as an insider of the company.

Rhea-AI Filing Summary

MiniMed Group, Inc. director Linnea Burman has filed an initial Form 3 reporting status as an insider of the company. The filing shows no reported transactions or holdings, with zero shares listed for purchases, sales, exercises, gifts, tax withholding, or restructurings.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the MiniMed Group (MMED) Form 3 filed by Linnea Burman show?

The Form 3 for MiniMed Group (MMED) shows director Linnea Burman’s initial insider reporting status. It reports no transactions and no share holdings, with zero activity for purchases, sales, exercises, gifts, or restructurings in this filing.

Did Linnea Burman buy or sell MiniMed Group (MMED) shares in this Form 3?

No. The Form 3 for MiniMed Group (MMED) reports zero shares bought, sold, exercised, gifted, or otherwise disposed of. It is purely an initial ownership statement without any trading activity disclosed in the filing data provided.

What insider role does Linnea Burman have at MiniMed Group (MMED)?

The filing identifies Linnea Burman as a director of MiniMed Group (MMED). She is not listed as an officer or ten percent owner in this Form 3, which serves to establish her status as a reportable insider with the SEC.

Does the MiniMed Group (MMED) Form 3 include any derivative securities for Linnea Burman?

No. The derivative section in the Form 3 for MiniMed Group (MMED) is empty, and the summary shows zero derivative transactions or remaining derivative positions, indicating no options, warrants, or similar instruments are reported for Linnea Burman here.

How much MiniMed Group (MMED) stock does Linnea Burman report owning on this Form 3?

Based on the provided data, the Form 3 for MiniMed Group (MMED) reports no share ownership and no transactions for Linnea Burman. All transaction-related share counts in the summary, including net activity, are reported as zero in this filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/06/2026 - 05:46 PM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Burman Linnea

(Last) (First) (Middle)

C/O MINIMED GROUP, INC.

18000 DEVONSHIRE STREET

(Street)

NORTHRIDGE CALIFORNIA 91325

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
06/29/2026

3. Issuer Name and Ticker or Trading Symbol
MiniMed Group, Inc. [ MMED ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit: Exhibit 24 - Power of Attorney

No securities are beneficially owned.

	/s/ Bryan F. Kelly, attorney-in-fact	07/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)